Credit: Procyrion, Inc.
DETROIT (June 3, 2021) - Cardiologists at Henry Ford Hospital are first in the U.S. and second in the world to implant a circulatory support device that is being investigated in a clinical trial for patients hospitalized with acute decompensated heart failure (ADHF) and worsening kidney function, a condition known as cardiorenal syndrome.
The Aortix™ System from Procyrion, Inc. is an intra-aortic axial flow pump, which is deployed via a femoral catheter to the descending aorta. This tiny pump, thinner than the size of a #2 pencil, is designed to relieve some of the heart s workload, allowing the heart to recover while more effectively pushing blood flow to the kidneys.
A national study on childhood asthma led by Henry Ford Health System has found that family history, race and sex are associated in different ways with higher rates of asthma in children.
Cardiologists at Henry Ford Hospital Led the Development of Shock Treatment Protocol
DETROIT (April 28, 2021) – The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Hospital in
Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply and can cause them to eventually cease functioning. The typical survival rate of this deadly complication during a heart attack has historically hovered around 50%.
Results from the National Cardiogenic Shock Initiative Demonstrate Significant Increase in Heart Attack Survival
Cardiologists at Henry Ford Hospital Led the Development of Shock Treatment Protocol
News provided by
Share this article
Share this article
DETROIT, April 28, 2021 /PRNewswire/ The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Hospital in collaboration with four metro Detroit hospitals.
William O Neill, M.D., William O’Neill, M.D., medical director of Henry Ford’s Center for Structural Heart Disease and principal investigator of the study.
Credit: Henry Ford Health System
DETROIT (April 28, 2021) - The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Hospital in collaboration with four metro Detroit hospitals.
Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body s needs, depriving vital organs of blood supply and can cause them to eventually cease functioning. The typical survival rate of this deadly complication during a heart attack has historically hovered around 50%.